Company page

Immupharma Plc

Immupharma Plc is a public company listed on the UK market under the ticker IMM, with a market capitalization of approximately £33.2 million. The company focuses on developing innovative pharmaceutical products, particularly in the field of immunology. Immupharma aims to address unmet medical needs through its research and development efforts.

IMM:LSEUpdated August 31, 2026
Immupharma Plc logo
Ticker
IMM:LSE
Asset type
Stock
Market cap
$29.7M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
LSE
Currency
GBX